Literature DB >> 12543454

Calmodulin and calmodulin-dependent kinase II mediate neuronal cell death induced by depolarization.

Hiromichi Takano1, Hiromichi Fukushi, Yoshiyuki Morishima, Yasufumi Shirasaki.   

Abstract

Depolarization has been known to play an important role in the neuronal damage that occurs following cerebral ischemia. In the present study, we investigated the roles of calmodulin (CaM) and CaM-dependent enzymes in depolarization-induced neuronal cell death. Treatment of primary cortical neurons with 10 microM veratridine, a voltage sensitive Na(+) channel activator, induced cell death as indicated by lactate dehydrogenase leakage from neurons. CaM antagonists (calmidazolium, trifluoperazine, W-7, and W-5) inhibited cell death induced by veratridine in a concentration-dependent manner. CaM kinase II (CaMKII) inhibitors (KN-62, KN-93, and myristoylated autocamtide-2 related inhibitory peptide), but not inhibitors of nitric oxide synthase or calcineurin, prevented veratridine-induced neuronal cell death. Veratridine rapidly activated CaMKII in neurons, and CaM antagonists and a CaMKII inhibitor suppressed the CaMKII activation. These results suggest that the CaM-CaMKII pathway contributes to depolarization-evoked cell death in neurons.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543454     DOI: 10.1016/s0006-8993(02)03932-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

1.  CaMKII activation is a novel effector of alcohol's neurotoxicity in neural crest stem/progenitor cells.

Authors:  Ana Garic; George R Flentke; Ed Amberger; Marcos Hernandez; Susan M Smith
Journal:  J Neurochem       Date:  2011-05-13       Impact factor: 5.372

2.  CaMKII and CaMKIV mediate distinct prosurvival signaling pathways in response to depolarization in neurons.

Authors:  Jinwoong Bok; Qiong Wang; Jie Huang; Steven H Green
Journal:  Mol Cell Neurosci       Date:  2007-06-27       Impact factor: 4.314

3.  Effective post-insult neuroprotection by a novel Ca(2+)/ calmodulin-dependent protein kinase II (CaMKII) inhibitor.

Authors:  Rebekah S Vest; Heather O'Leary; Steven J Coultrap; Mark S Kindy; K Ulrich Bayer
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

Review 4.  CaMKII in cerebral ischemia.

Authors:  Steven J Coultrap; Rebekah S Vest; Nicole M Ashpole; Andy Hudmon; K Ulrich Bayer
Journal:  Acta Pharmacol Sin       Date:  2011-06-20       Impact factor: 6.150

5.  Differential modulation of 7-ketocholesterol toxicity against PC12 cells by calmodulin antagonists and Ca2+ channel blockers.

Authors:  Chung Soo Lee; Woo Jae Park; Eun Sook Han; Hyoweon Bang
Journal:  Neurochem Res       Date:  2006-12-07       Impact factor: 3.996

6.  Gene expression profile in rat dorsal root ganglion following sciatic nerve injury and systemic neurotrophin-3 administration.

Authors:  Lu-Ting Kuo; Shao-Yu Tsai; Michael J Groves; Shu F An; Francesco Scaravilli
Journal:  J Mol Neurosci       Date:  2011-03       Impact factor: 3.444

7.  Curcumin Inhibits Neuronal Loss in the Retina and Elevates Ca²⁺/Calmodulin-Dependent Protein Kinase II Activity in Diabetic Rats.

Authors:  Jun Li; Peipei Wang; Yanxia Zhu; Zhen Chen; Tianyan Shi; Wensheng Lei; Songping Yu
Journal:  J Ocul Pharmacol Ther       Date:  2015-07-24       Impact factor: 2.671

Review 8.  Negative regulation of multifunctional Ca2+/calmodulin-dependent protein kinases: physiological and pharmacological significance of protein phosphatases.

Authors:  A Ishida; N Sueyoshi; Y Shigeri; I Kameshita
Journal:  Br J Pharmacol       Date:  2008-05-05       Impact factor: 8.739

9.  Glutamate-induced NFkappaB activation in the retina.

Authors:  Wei Fan; Nigel G F Cooper
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-03       Impact factor: 4.799

10.  Calcium/Calmodulin-Dependent Kinase (CaMKII) Inhibition Protects Against Purkinje Cell Damage Following CA/CPR in Mice.

Authors:  Nicholas E Chalmers; Joan Yonchek; Kathryn E Steklac; Matthew Ramsey; K Ulrich Bayer; Paco S Herson; Nidia Quillinan
Journal:  Mol Neurobiol       Date:  2019-09-13       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.